FDA action reinforces that compounded GLP-1 alternatives are not approved drugs Hims & Hers retreat highlights the business risk when regulatory and legal interests collide with aggressive medical marketing Novo Nordisks lawsuit underscores how intellectual property protections are being actively enforced in the GLP-1 market
Inositol becomes the fat's chauffeur, ensuring it reaches its destination
Clinical pharmacokinetics and pharmacodynamics: concepts and applications
Others, including taspoglutide, failed through high incidence of side-effects or insufficient efficacy
Prioritize Regular Dental Check-ups and Open Communication Inform Your Dental Team : It is crucial to inform your dentist and hygienist that you are taking a GLP-1 agonist, even if you are not currently experiencing dental issues
When clinically appropriate, our North Raleigh providers may prescribe GLP-1 medications including semaglutide and tirzepatide as part of a physician-supervised weight loss program